5th Annual Monoclonal Antibodies Conference: March 24-25, 2009, London, UK
- PMID: 20073132
- PMCID: PMC2726607
- DOI: 10.4161/mabs.1.4.8956
5th Annual Monoclonal Antibodies Conference: March 24-25, 2009, London, UK
Abstract
The conference, which was organized by Visiongain and held at the BSG Conference Center in London, provided an excellent opportunity for participants to exchange views on the development, production and marketing of therapeutic antibodies, and discuss the current business environment. The conference included numerous interactive panel and group discussions on topics such as isotyping for therapeutic antibodies (panel chair: Nick Pullen, Pfizer), prospects for fully human monoclonal antibodies (chair: Christian Rohlff, Oxford BioTherapeutics), perspectives on antibody manufacturing and development (chair: Bo Kara, Avecia), market impact and post-marketing issues (chair: Keith Rodgers, Bodiam Consulting) and angiogenesis inhibitors (chair: David Blakey, AstraZeneca).
Similar articles
-
Advances in the applications of monoclonal antibodies in clinical oncology. Proceedings of the 5th international meeting. London, UK, 25-27 May 1988.Int J Cancer Suppl. 1988;3:1-103. Int J Cancer Suppl. 1988. PMID: 3209294 No abstract available.
-
Monoclonal Antibodies -- Visiongain's Second Annual Meeting. 29-30 June 2005, London, UK.IDrugs. 2005 Sep;8(9):713-5. IDrugs. 2005. PMID: 16118689 No abstract available.
-
Drug Discovery Technology Europe 2004--IBC's Eighth Annual Conference and Exhibition. 9-10 March 2003, London, UK.IDrugs. 2004 Apr;7(4):334-8. IDrugs. 2004. PMID: 15057639 No abstract available.
-
The safety and side effects of monoclonal antibodies.Nat Rev Drug Discov. 2010 Apr;9(4):325-38. doi: 10.1038/nrd3003. Epub 2010 Mar 22. Nat Rev Drug Discov. 2010. PMID: 20305665 Review.
-
[Monoclonal antibodies in the treatment of malignant lymphoma].Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2006 Jun;28(3):435-41. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2006. PMID: 16900652 Review. Chinese.
References
-
- Reichert JM. Monoclonal Antibodies as Innovative Therapeutics. Current Pharma Biotechnol. 2008;9:423–430. - PubMed
-
- Nelson AL, Reichert JM. Development trends for therapeutic antibody fragments. Nat Biotechnol. 2009;4:331–337. - PubMed
-
- Abuchowski A, McCoy JR, Palczuk NC, van Es T, Davis FF. Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. J Biol Chem. 1977;252:3582–3586. - PubMed
-
- Chapman AP. PEGylated antibodies and antibody fragments for improved therapy: A review. Adv Drug Deliv Rev. 2002;54:531–545. - PubMed
-
- Davis JM, Pennington JE, Kubler AM, Conscience JF. A simple, single-step technique for selecting and cloning hybridomas for the production of monoclonal antibodies. J Immunol Methods. 1982;50:161–171. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous